Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | COX6A2 |
| Upstream (Parents) |
|---|
| (<<) MYL2 → COX6A2 |
| (<<) MYOT → COX6A2 |
| (<<) TNNI1 → COX6A2 |
| (<<) MYLPF → COX6A2 |
| (<<) ENO3 → COX6A2 |
| Downstream (Children) |
|---|
| COX6A2 → TSHB (>>) |
| COX6A2 → CTRL (>>) |
| COX6A2 → MYOT (>>) |
| COX6A2 → NOL4 (>>) |
| COX6A2 → NRAP (>>) |
| COX6A2 → RPL3L (>>) |
| COX6A2 → CBX2 (>>) |
| COX6A2 → CACNA1S (>>) |
| COX6A2 → ENO3 (>>) |
| COX6A2 → PCDHB3 (>>) |
| COX6A2 → S100A1 (>>) |
| COX6A2 → MYOG (>>) |
| COX6A2 → ATP12A (>>) |
| COX6A2 → DUSP13 (>>) |
| COX6A2 → ART1 (>>) |
